Position in NTRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,416,329
-$10,371,171 QoQ
Shares Held
34,689
-72.2% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#210
of 844 holders
Holding Since
Sep 2022
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PERCEPTIVE ADVISORS LLC holds $89,317,840 across 9 Diagnostics & Research names. NTRA ranks #4 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRL |
Charles River Laboratories International, Inc.
|
140,000 | $31,750,600 | |
| 2 | DHR |
Danaher Corp /De/
|
130,000 | $24,762,400 | |
| 3 | BLLN |
BillionToOne, Inc.
|
86,812 | $10,415,703 | |
| 4 | NTRA |
Natera, Inc.
This page
|
34,689 | $9,416,329 | |
| 5 | GH |
Guardant Health, Inc.
|
41,327 | $6,200,289 | |
| 6 | TWST |
Twist Bioscience Corp
|
36,812 | $3,787,218 | |
| 7 | BDSX |
Biodesix Inc
|
108,694 | $2,451,049 | |
| 8 | XGN |
Exagen Inc.
|
114,893 | $534,252 |
All Filings in NTRA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,416,329 | 34,689 | Shares | Sole | 2026-08-14 | |
| 2024-12-31 | $19,787,500 | 125,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $27,929,000 | 220,000 | Shares | Sole | 2024-11-14 | |
| 2023-09-30 | $9,654,376 | 218,178 | Shares | Sole | 2023-11-14 | |
| 2022-12-31 | $5,222,100 | 130,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,258,400 | 120,000 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||